2-(2-fluoro-6-nitrophenyl)ethan-1-ol | 118665-03-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(2-fluoro-6-nitrophenyl)ethan-1-ol
• 英文别名: 2-(2-fluoro-6-nitrophenyl)ethanol；2-Fluoro-6-nitrophenethyl alcohol
• CAS: 118665-03-5
• 化学式: C₈H₈FNO₃
• 分子量: 185.155
• InChiKey: XDEZTMHEXGNPHP-UHFFFAOYSA-N

物化性质

• 沸点：
  292.0±25.0 °C(Predicted)
• 密度：
  1.363±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  66
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(2-fluoro-6-nitrophenyl)ethan-1-ol 在 吡啶 、 三乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 7.5h， 生成 5'-O-(2-(2-fluoro-6-nitrophenyl)ethoxycarbonyl)thymidine
  参考文献：
  名称：

  Photolabile protecting groups for nucleosides: Synthesis and photodeprotection rates

  摘要：

  o-Nitrobenzyloxycarbonyl and a number of related groups have been tested for the photolabile protection of nucleoside 5'-hydroxyls. The rates of photodeprotection were found to vary by approximately 17 fold in a series of 5'-O-protected thymidine derivatives irradiated at 365 nm under identical conditions. The homologous 2-(o-nitrophenyl)ethoxycarbonyl group and its derivatives were found to be removed approximately 2-fold faster than the corresponding o-nitrobenzyloxycarbonyl group, possibly due to an increased rare of alpha-hydrogen abstraction by the photo-excited nitro group. Photolysis rates were affected by substitutions on both the phenyl ring and alpha-carbon, with the strongest rate enhancements caused by the presence of a methyl or second o-nitrophenyl group in the alpha-position. Among the ring-substituted derivatives studied, o-nitro and o-iodo had the strongest enhancement effects on photodeprotection, while an o-fluoro group reduced the rate of photodeprotection. In general, substitutions at other positions on the phenyl ring had less effect on photolysis rates. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0040-4020(97)00154-3
• 作为产物：
  描述：

  2-氟-6-硝基甲苯 在 氢氧化钾 、 paraformaldehyde 作用下， 以 乙醇 、 二甲基亚砜 为溶剂， 生成 2-(2-fluoro-6-nitrophenyl)ethan-1-ol
  参考文献：
  名称：

  Production of substituted 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic

  摘要：

  生产具有有用的镇痛和抗炎活性的取代1,3,4,9-四氢吡喃[3,4-b]吲哚-1-乙酸的过程。

  公开号：

  US04822893A1

文献信息

• Ruthenium Pincer Complex Catalyzed Selective Synthesis of C‐3 Alkylated Indoles and Bisindolylmethanes Directly from Indoles and Alcohols
  作者：Nandita Biswas、Rahul Sharma、Dipankar Srimani

  DOI：10.1002/adsc.202000326

  日期：2020.7.29

  catalyst for C‐3 alkylation of 1H‐indoles with various aliphatic primary and secondary alcohols including cyclic alcohols as well as benzylic alcohols. The selective synthesis of bisindolylmethane derivatives is also achieved from the same set of indole and alcohol just by altering the reaction parameters. Furthermore, the sustainable synthesis of C‐3 alkylated indoles directly from 2‐(2‐nitrophenyl)ethan‐1‐ol

  在此，我们介绍了Ru-SNS配合物，该配合物可作为1H-吲哚与各种脂族伯醇和仲醇（包括环状醇以及苄醇）的C-3烷基化的有用催化剂。仅通过改变反应参数，就可以从同一组吲哚和醇中选择性地合成双吲哚基甲烷衍生物。此外，据报道，直接由2-（2-硝基苯基）乙-1-醇和Ru-络合物通过“借用氢”策略催化的醇可持续合成C-3烷基化的吲哚。该协议提供了一种原子经济的可持续途径，可用于访问结构上重要的化合物，如金刚烷，颤敏A和色胺基衍生物。
• Nucleoside derivatives with photolabile protective groups
  申请人：Pfleiderer; Wolfgang

  公开号：US05763599A1

  公开（公告）日：1998-06-09

  The invention relates to nucleoside derivatives having photolabile protective groups of the general formula (I) ##STR1## in which R.sup.1 .dbd.H, NO.sub.2, CN, OCH.sub.3, halogen or alkyl or alkoxyalkyl having 1 to 4 C atoms R.sup.2 .dbd.H, OCH.sub.3 R.sup.3 .dbd.H, F, Cl, Br, NO.sub.2 R.sup.4 .dbd.H, halogen, OCH.sub.3, or an alkyl radical having 1 to 4 C atoms R.sup.5 .dbd.H or a usual functional group for preparing oligonucleotides R.sup.6 .dbd.H, OH, halogen or XR.sup.8, where X.dbd.O or S and R.sup.8 represents a protective group usual in nucleotide chemistry, B=adenine, cytosine, guanine, thymine, uracil, 2,6-diaminopurin-9-yl, hypoxanthin-9-yl, 5-methylcytosin-1-yl, 5-amino-4-imidazolcarboxamid-1-yl, or 5-amino-4-imidazolcarboxamid-3-yl, where in the case of B=adenine, cytosine or guanine, the primary amino function optionally exhibits a permanent protective group. These derivatives may be used for the light-controlled synthesis of oligonucleotides on a DNA chip.

  该发明涉及具有通式（I）的光敏保护基的核苷衍生物##STR1##其中R.sup.1 =H、NO.sub.2、CN、OCH.sub.3、卤素或具有1至4个碳原子的烷基或烷氧基烷基R.sup.2 =H、OCH.sub.3 R.sup.3 =H、F、Cl、Br、NO.sub.2 R.sup.4 =H、卤素、OCH.sub.3或具有1至4个碳原子的烷基基团R.sup.5 =H或用于制备寡核苷酸的常见功能基R.sup.6 =H、OH、卤素或XR.sup.8，其中X=O或S，R.sup.8代表核苷酸化学中常见的保护基，B=腺嘌呤、胞嘧啶、鸟嘌呤、胸腺嘧啶、尿嘧啶、2,6-二氨基嘌呤-9-基、次黄嘌呤-9-基、5-甲基胞嘧啶-1-基、5-氨基-4-咪唑甲酰胺-1-基或5-氨基-4-咪唑甲酰胺-3-基，其中在B=腺嘌呤、胞嘧啶或鸟嘌呤的情况下，初级氨基功能可选择具有永久保护基。这些衍生物可用于在DNA芯片上进行光控合成寡核苷酸。
• [EN] 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES<br/>[FR] DÉRIVÉS DE 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
  申请人：BAYER AG

  公开号：WO2020216774A1

  公开（公告）日：2020-10-29

  Compounds of formula (I) for use in the treatment or prophylaxis of a disease, which is a hyperproliferative disease and/or a disorder responsive to induction of cell death, selected from a haematological tumour, a solid tumour and/or metastases thereof, said tumour harbouring a mutant EGFR with exon 19 or 21 mutations, and their use as pharmaceuticals.

  式(I)的化合物用于治疗或预防一种高增殖性疾病和/或对诱导细胞死亡敏感的疾病，所述疾病选自血液肿瘤、实体肿瘤和/或其转移瘤，所述肿瘤携带具有外显子19或21突变的突变EGFR，并将其用作药物。
• [EN] OX1 ANTAGONISTS<br/>[FR] ANTAGONISTES D'OX1
  申请人：HEPTARES THERAPEUTICS LTD

  公开号：WO2019086902A1

  公开（公告）日：2019-05-09

  The disclosures herein relate to novel compounds of formula (1) and salts thereof, wherein X;Y; R1; R2; R3; R4; R5; R6; R7 and R8 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors..

  本公开涉及公式（1）及其盐的新化合物，其中X；Y；R1；R2；R3；R4；R5；R6；R7和R8在此处定义，并其在治疗、预防、改善、控制或减少与促觉素受体相关的神经系统或精神障碍的风险方面的用途。
• Tricyclic compound or salts thereof, method for producing the same and
  申请人：Wakunaga Seiyaku Kabushiki Kaisha

  公开号：US05399553A1

  公开（公告）日：1995-03-21

  A tricyclic compound represented by the general formula (1) and salts thereof are disclosed. ##STR1## A method for producing the tricyclic compound and salts thereof, and an antimicrobial agent containing the tricyclic compound and salts thereof as an active ingredient are also disclosed.

  本发明公开了一种由一般式（1）表示的三环化合物及其盐。##STR1##本发明还公开了制备该三环化合物及其盐的方法，以及含有该三环化合物及其盐作为活性成分的抗微生物剂。